Recherche
-
Real-world outcomes following 12 months of intravitreal aflibercept monotherapy in patients with diabetic macular edema in France: results from the APOLLON study
(Graefe's Archive for Clinical and Experimental Ophthalmology. vol. 258, n° 3, pp. 521-528, 2020)Article de revueLibre accès -
Two-year outcomes of the APOLLON observational study of intravitreal aflibercept monotherapy in France in patients with diabetic macular edema
(Scientific Reports. vol. 12, n° 1, 2022-10-29)Article de revueLibre accès -
Visual Acuity Gain Profiles and Anatomical Prognosis Factors in Patients with Drug-Naive Diabetic Macular Edema Treated with Dexamethasone Implant: The NAVEDEX Study
(Pharmaceutics. vol. 13, n° 2, 2021-02-01)Article de revueLibre accès